Company: IMCR
Filing Date: 2025-01-02
Form Type: 8-K
Source: 0001140361-25-000008
Chunk: 2

Company: Immunocore Holdings plc
Filing Date: 2025-01-02
Form: 8-K
Item: Item 5.02
Chunk 2
---
 form of continuation of Mr. Coy’s then-current base salary for 12 months, and (b) payment of his COBRA
premiums for up to 12 months.

There are no arrangements or understandings between Mr. Coy and any other person pursuant to which he was selected as an officer of the Company, and
there is no family relationship between Mr. Coy and any of the Company’s other executive officers or directors. There are no transactions between Mr. Coy and the Company that require disclosure pursuant to Item 404(a) of Regulation S-K.

The foregoing description of the Employment Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the complete text
of the Employment Agreement, a copy of which the Company expects to file with its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and, upon filing, it will be incorporated herein by reference.